SciSparc unit NeuroThera Labs wins Japanese patent for paracetamol combination therapy

Reuters2026/08/12 12:25

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

SciSparc unit NeuroThera Labs secured a Japanese patent covering a proprietary drug-combination platform aimed at enhancing paracetamol-class therapies.
Patent covers compositions pairing 4-aminophenol derivatives with N-acylethanolamines to boost analgesic, antipyretic performance.
NeuroThera targets lower effective dosing to reduce dose-related side-effect risk, strengthening its intellectual property position in Japan.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Scisparc Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608120825PRIMZONEFULLFEED9808623) on August 12, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

SciSparc unit NeuroThera Labs wins Japanese patent for paracetamol combination therapy

You may also like

Crypto prices